Status:
RECRUITING
Translation and Validation of the COMM and ASI-SR
Lead Sponsor:
Uppsala University
Collaborating Sponsors:
The Kamprad Family Foundation for Entrepreneurship, Research & Charity
Conditions:
Opioid Use
Opioid Use Disorder
Eligibility:
All Genders
18-75 years
Brief Summary
The goal of this observational study is to translate the COMM (Current opinion misuse measure) form and validate it using the ASI-SR (Addiction severity score-self report)in a Swedish population of pa...
Detailed Description
There is no validated instrument for the assessment of early detection of substance use disorder development in swedish language. In order to address this gap, investigators plan to translate and val...
Eligibility Criteria
Inclusion
- Intervention group:
- Patients with long-term, non-cancer-related pain (\>3 months) at least 3 days a week
- opioid treatment for at least 1 month during last 6 months
- age 18-75 years
- fluent in spoken and written Swedish.
- Control group:
- Patients with long-term, non-cancer-related pain (\>3 months) at least 3 days a week
- no opioid treatment at inclusion and during last 3 months
- age 18-75 years
- fluent in spoken and written Swedish
Exclusion
- ongoing diseases or conditions that prevents the patient from completing to the study according to the doctor's assessment
- serious cognitive disorder that makes answering the questions impossible. - - ongoing or treated cancer in the last 10 years
- Insufficient knowledge of Swedish
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06084520
Start Date
December 1 2023
End Date
December 31 2026
Last Update
May 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Multidisciplinary Pain Center
Uppsala, Uppland, Sweden, 75185